NCT00759395View on ClinicalTrials.gov

Study of Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder (AMDD)

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Anxious Major Depressive Disorder
Interventions
DRUG

AZD2327

Tablet, Oral, Daily

DRUG

Placebo

Tablet, Oral, Daily

Trial Locations (1)

Unknown

Research Site, Baltimore

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY